 We induced white matter infarction by stereotactic injection of endothelin-1 (ET-1) together with N(G)-nitro-L-arginine methyl ester (L-NAME) into the internal capsule of VEGFR2-GFP:: VEGFR1-tdsRed double transgenic mice.
A C C E P T E D M A N U S C R I P T
Introduction
Subcortical white matter infarction causes ischemic demyelination, loss of brain functions, and substantial handicap as a result of disturbances of the blood flow [2] . Although early infarction could be asymptomatic, it is progressive, resulting in cognitive and motor dysfunction. It is the A C C E P T E D M A N U S C R I P T second leading cause of dementia [14] . Immediately following the interruption of the blood flow to brain tissue, the progressive decrease of the oxygen concentration initiates the death of cells in the ischemic lesion, unless recovery of the normal blood flow occurs within a short time [7] . Capillary endothelial cells, too, die under hypoxic condition, because of their high rate of oxidative metabolism [9] . Endothelial cells are also very vulnerable to the reactive oxygen species produced in the reperfusion stage of the ischemic insult [20] . The dynamics of vascularization in detail after the white matter infarction, however, is still unclear. This is one of the reasons why the fundamental therapeutic strategies for the white matter infarction have not been established. Another reason is the paucity of researches using the white matter infarction animal models compared with the large artery occlusion models, as the volume of white matter in rodents is much smaller than that in primates [18] .
The present study aimed to examine the dynamics of revascularization after the white matter infarction in mice. We induced white matter infarction by stereotactic injection of endothelin-1 (ET-1), a potent vasoconstrictor, together with N(G)-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, into the internal capsule of mice. The dynamics of revascularization can be monitored in Fetal liver kinase 1 (Flk1; also called VEGF-R2)-GFP:: c-fms-like tyrosine kinase 1 (Flt1; also called VEGF-R1)-tdsRed double transgenic mice [15] . GFP and tdsRed fluorescence is observed within blood vessels, because Flk1 and Flt1 are both expressed in endothelial cells. We found that revascularization begins early after the ischemic insult. We also found the emerging pericytes first ensheath blood vessels and then produce fibroblast-like cells not in close contact with blood vessels.
Materials and Methods

Animals
We used male and female Flk1-GFP BAC transgenic mice, Flk1-GFP::Flt1-tdsRed BAC transgenic mice, and ICR wild type mice (10-to 12-week old). As we previously reported [13,
, we used BAC clones that carry the whole Flk1 or Flt1 genomic region as well as the upstream and downstream regions. The GFP and tdsRed cDNA were introduced into the first exon of the Flk1 and Flt1 gene using the RED/ET recombination technique respectively. The resulting GFP and tdsRed carrying BAC transgene were injected into pronuclei to create Flk1-GFP and Flt1-tdsRed BAC Tg animals respectively. The expression level of baseline was high for both Flk1-GFP and Flt1-tdsRed, as shown in Fig. 2A . All procedures were performed in accordance with the guidelines for Animal Experimentation at Gunma University Graduate School of Medicine and were approved by Gunma University Ethics Committee (Permit Number:16-009).
Stereotactic ET-1/L-NAME injection
We injected endothelin-1 (ET-1) / N(G)-nitro-L-arginine methyl ester (L-NAME) into the internal capsule as previously described with some modifications [19] . Mice were anesthetized with isoflurane. Mice were placed in a stereotactic frame attached with 33G needle. For injection into the internal capsule, we set the needle tip on the bregma angled with 22°, moved the needle 0.8-1.1 mm posterior and 3.1-3.3 mm lateral left, and inserted the needle into the brain parenchyma 3.9-4.1 mm ventral from the skull surface angled with 22° keeping. Two microliters of ET-1 (100 pmol/µl, 1 µl, Peptide Institute, Japan) / L-NAME solution (2.7mg/ml, 1 µl, Sigma) mixture dissolved in phosphate buffered saline (PBS) were injected. The day of injection of ET-1/L-NAME was designated as 0 day post lesion (0 dpl).
Magnetic resonance imaging
Magnetic resonance (MR) imaging was carried out 1 day after the ET-1/L-NAME injection by a 1-T benchtop MR scanner (Icon; Bruker Biospin, Germany). Mice were anesthetized with isoflurane. T2-weighted image was used to detect the infarction area: repetition time 2000 ms, echo time 85 ms, thickness 760 µm and interslice distance 760 µm.
Cryosection
Mice were anesthetized deeply with isoflurane and perfused transcardinally with 4% paraformaldehyde in PBS. The brains were dissected and post-fixed with 4% paraformaldehyde in PBS for 1 h, and were cryoprotected with 30% sucrose in PBS at 4C. Frozen sections (20 μm in thickness) were cut coronally using a cryostat (CM3050S; Leica Biosystems, Germany).
Immunofluorescent staining
The brain sections were fixed with 10% formalin neutral buffer solution, washed with PBS containing 0.3% Triton X-100 (PBS-T), incubated with 2-3% bovine serum albumin (BSA) in PBS-T for 60 min, and incubated with primary antibodies at 4C overnight. Primary antibodies included anti-GFP rabbit polyclonal (1:1000; MBL, Japan), anti-PDGFRβ goat polyclonal (1:100; R&D systems, USA). After washing with PBS-T, sections were incubated with fluorophore-conjugated secondary antibodies for 2 h at room temperature. Hoechst 33342 (1 μg/ml; Invitrogen) was used for nuclear staining. For Ki-67 detection, sections were immunostained with an anti-GFP antibody beforehand, fixed with 10% formalin neutral buffer solution again, heated in citrate buffer (pH 6) for 5 min using a microwave oven, incubated with 2% BSA in PBS-T, and incubated with an anti-Ki67 mouse monoclonal antibody (1:200; BD Pharmingen, USA). For fibronectin detection, sections were immunostained with an anti-fibronectin rabbit polyclonal antibody (1:200; Abcam, United Kingdom) using TSA system (Perkin Elmer, USA). Sections were observed using a fluorescence microscope (BZ-X710, BZ-9000; Keyence, Japan) and confocal laser-scanning microscope (LSM880; Carl Zeiss, Germany).
Luxol fast blue staining
To identify ischemic demyelinated lesions in the internal capsule, brain sections were stained with Luxol fast blue (LFB) as previously described [17] .
Blood flow analysis
Blood flow in and around the ET-1/L-NAME injected lesion was assessed by injection of streptavidin-Alexa Fluor 350 (100 µg/100 µl) (Thermo Fisher Scientific, USA) -labeled biotinylated lycopersicon esculentum (tomato) lectin (100 µg/100 µl) (Vector Laboratories, USA) transcardially.
Mice were anesthetized with isoflurane before intracardial injection of the labeling solution described above. Five min later mice were perfused transcardially with 4% paraformaldehyde in PBS, and cryosections were prepared as mentioned above.
Quantitative real-time RT-PCR
Fresh coronal sections (thickness; 1 mm) were cut with a brain slicer (Muromachi Kikai, Japan). The internal capsule from two brain slices per one brain was dissected on an ice-cold metal plate immediately. Total RNA was extracted using ISOGEN (Nippon gene, Japan). Quantitative PCR was performed with Applied Biosystems 7500 Real-Time PCR System using SYBR Green PCR master mix (Applied Biosystems) to validate the differences. The ∆∆Ct method was used for relative quantification of Pdgfb gene expression. Gapdh was used as the reference gene. Significant differences were determined with a paired t-test. The primers used were: PDGF-B (sense, 5'-CATCCGCTCCTTTGATGATCTT-3'; antisense, 5' -GTGCTCGGGTCATGTTCAAGT-3'), GAPDH (sense, 5'-ATGGTGAAGGTCGGTGTGAACG -3'; antisense, 5'-CGCTCCTGGAAGATGGTGATGG -3').
Analysis of vessel area
The area of Flt1-tdsRed-positive vessels and Flk1-GFP-strongly-positive vessels were measured using ImageJ software. Using LFB stained image, the ROI (region of interest) was defined on the demyelinated region in the internal capsule for the ipsilateral side, and on the internal capsule for contralateral side, respectively. The threshold of fluorescent intensity was determined to obtain
binary images. The area covered by the blood vessel-like structures with Flt1-tdsRed fluorescence or Flk1-GFP strong fluorescence in the determined ROI was measured. Data are presented as the mean ± SD. The data were analyzed with freely available statistical software EZR.
Results and Discussion
ET-1/L-NAME injection induced demyelination in the internal capsule of mice
In previous studies, we induced white matter infarction in rat brains by ET-1 injection into the internal capsule, and found that transplantation of microvascular endothelial cells significantly promoted the recovery of the infarction [12, 17] . Since we needed to use Flk1-GFP::Flt1-tdsRed double transgenic mice to examine the changes in blood vessels in this study, we tried to induce white matter infarction by injecting ET-1 into mouse brains. ET-1 injection alone (80-100 pmol), however, did not stably induce white matter infarction in mice (Fig. S1 ). Hence we injected L-NAME as well as ET-1 into the internal capsule of mice as previously reported [19] . Injection of ET-1 and L-NAME together induced infarction in the mouse internal capsule. To follow infarction after the injection, we captured MR T2-weighed images 1 day after ET-1/L-NAME injection (1 day post lesion;1 dpl). MR imaging showed a high intensity area in the internal capsule (Fig. 1) , indicating that focal infarction was induced in the internal capsule at 1 dpl. We performed LFB staining of brain sections made from the same mouse at 7 dpl (Fig. 1) . The LFB staining at 7 dpl showed obvious demyelinated lesion at the same area as MR T2-weighted image showed. These data indicated that injection of ET-1/L-NAME together effectively induced focal infarction and demyelination in the internal capsule of mice.
Visualization of revascularization in white matter infarction
It was reported that the density of lectin-perfused vessels of the internal capsule was reduced by 85% 7 days after ET-1/L-NAME injection [19] . This indicates that small vessel
constriction mediated by the ET-1/L-NAME injection was not recovered within 7 days. Hence we analyzed the dynamics of blood vessel loss and revascularization in the internal capsule after the white matter infarction within 7 days using the double transgenic mice (Flk1-GFP::Flt1-tdsRed tg mice) [15] . Matsumoto and others showed that Flt1-tdsRed expression overlapped well with that of Flk1-GFP, and Flt1 was expressed more abundantly in endothelial cells of large blood vessels such as dorsal aorta at developmental stage [15] . Furthermore, they showed Flt1 expression was seen in most endothelial cells but was relatively weak in newly forming endothelial sprouts, while Flk1 expression was more prominent in newly forming endothelial sprouts and relatively weak in dorsal aorta at embryonic stage. Therefore, we used Flk1-GFP::Flt1-tdsRed double Tg mice to monitor the preexisting blood vessels (visualized by tdsRed) and the angiogenic vessel growth (visualized by GFP) after the white matter infarction. The fluorescence of GFP and tdsRed changed throughout our experimental time course in the infarction area ( Fig. 2A and 2B ). The demyelinated lesions in the internal capsule determined by LFB staining (Fig. 1) were used to identify the white matter infarction region, and the changes in the blood vessels were analyzed in this area (Fig. 2) . We saw Flt1-tdsRedpositive blood vessels on the contralateral side ( Fig. 2A) . These Flt1-tdsRed-positive blood vessels apparently decreased on the ET-1/L-NAME-injected side when compared to the contralateral (intact) side (Fig. 2B) . By contrast, the Flk1-GFP-strongly-positive vessels were prominent only on the ipsilateral side, and they increased as time elapsed (Fig. 2B) . We then quantified these changes by computer-based densitometric analysis. As seen in Fig. 2B , we always observed an increase in the basal level of green fluorescence in the infarct region. So we quantified the area covered by the blood vessel-like structures with Flt1-tdsRed or Flk1-GFP fluorescence. Consistent with the images ( Fig.   2A and 2B ), the area covered by Flt1-tdsRed-positive blood vessels on the ipsilateral side was significantly decreased when compared to that on contralateral side at 1 dpl or 5 dpl (Fig. 2C) .
Although there was no significant difference at 7 dpl, the reduction of the area covered by Flt1-tdsRed-positive vessels on the ipsilateral side seemed to continue for a week (Fig. 2C) , suggesting that the vascularization was not recovered within a week. In contrast to the changes in the area
covered by Flt1-tdsRed-positive vessels, the area covered by Flk1-GFP-strongly-positive blood vessels on the ipsilateral side increased when compared to that on the contralateral side in a timedependent manner ( Fig. 2A, 2B, and 2D) . These results indicate that the ET-1/L-NAME-injection resulted in vascular loss at 1 dpl and induced angiogenesis from 3 dpl, and the angiogenesis still remained active at 7 dpl.
We observed Flk1-GFP-strongly-positive blood vessels both in the periphery ( Fig. 2B; 3 dpl, arrows) and the core ( Fig. 2B; 7 dpl, arrows) of the internal capsule on the ipsilateral side. To further examine the revascularization in the infarct area, we obtained images by a confocal laserscanning microscope ( Fig. 3 and S2) . We observed that Flk1-GFP-strongly-positive structures were tubular (Fig. 3B , arrow) and branching (Fig. 3C, arrow) . When we examined whether the blood flew in the Flk1-GFP-strongly-positive vessels by fluorescence-labelled lectin perfusion at 7 dpl, it was evident that the blood flew in some of these vessels, as some Flk1-GFP-strongly-positive vessels were labelled by the lectin (Fig. 3D and 3E) . Furthermore, we found Ki67-positive endothelial cells in Flk1-GFP-strongly-positive vessels, suggesting that angiogenesis was occurring in this area ( Fig.   3F and 3G ).
Flk1 is the major mediator of the angiogenic effect exerted by VEGF-A [5] . Flt1 is also a high affinity receptor for VEGF-A, but dispensable for vascular morphogenesis in vivo, presumably acting as a decoy receptor [10, 16] . In the infarct region, we observed appearance of the Flk1-strongly-positive blood vessels (Fig. 2B ) from 3 dpl, indicating the occurrence of active angiogenesis at this time point. Adamczak and others monitored the change of Flk1 expression in blood vessels after temporary middle cerebral artery occlusion (MCAO) using Flk1-luciferase reporter mice, and revealed that Flk1 expression started 3 days after the insult with peak values at 7 day [1] . This report suggested that VEGF-Flk1 signaling might be important for angiogenesis after temporary MCAO. In our study, Flk1-GFP-strongly-positive blood vessels on the ipsilateral side increased when compared to that on the contralateral side within 7 days (Fig. 2) . Their report and ours suggest that VEGF-Flk1 signaling might be the common regulator of angiogenesis after ischemia induced both by temporal A C C E P T E D M A N U S C R I P T large artery occlusion and permanent occlusion in deep white matter by ET-1/L-NAME-injection.
The PDGFRβ-strongly-positive cells increased in the infarct area
We showed new blood vessels are formed in the core of white matter infarction in the acute phase (Figs. 2 and 3) . It is well known that the interaction between pericytes and endothelial cells is essential for vessel stability and maturation [3] . Hence we examined the association between pericytes and the blood vessels in the white matter infarction after ET-1/L-NAME injection (Fig. 4) .
In this part, we used the Flk1-GFP BAC Tg mice and wild type mice, instead of the double transgenic mice (Flk1-GFP::Flt1-tdsRed Tg mice) to visualize the pericytes "red" after immunofluorescence staining for PDGFRβ, a marker for pericytes. The expression of PDGFRβ in pericytes was very weak under physiological conditions (not shown). The PDGFRβ-strongly-positive (PDGFRβ+) cells were not apparent at 1 dpl, but became prominent at 3 dpl and increased their number thereafter in the infarct area (Fig. 4A ). This result is consistent with the previous report that PDGFRβ expression by the pericytes is upregulated in the MCAO model, while its expression is low in the intact mature brain [4] . At 3 dpl, most of these cells were in close contact with Flk1-GFPpositive endothelial cells, indicating these cells are bona fide pericytes (arrows in Fig. 4A ). At 7 dpl, the number of PDGFRβ+ cells increased dramatically, and some of these PDGFRβ+ cells ensheathed the GFP-positive blood vessels (the rectangle in Fig. 4A is shown at higher magnification in B, and arrows in B show pericytes ensheathing blood vessels). We quantified the area covered by PDGFRβ+ cells (Fig. 4C) . Consistent with the images (Fig. 4A) , the area covered by PDGFRβ+ cells in the demyelinated lesion at 7dpl significantly increased compared to that at 1 dpl. These results indicate that pericytes appeared together with newly formed blood vessels in the infarct area. Platelet-derived growth factor B (PDGF-B), a ligand for PDGFRβ, is necessary for pericyte recruitment during angiogenesis [3] . We analyzed the changes in the expression of PDGF-B in the white matter infarction, and found that the expression of pdgfb mRNA increased on the ET-1/L-NAME-injected side in the internal capsule when compared with the contralateral side (Fig. 4D) . These data suggest a (Fig. 4) . Second, it has been reported that PDGF-B is secreted by the migratory tip cells at the leading edge of angiogenic sprout [8] . As shown in Fig. 4A , the vast majority of PDGFRβ+ cells at 7 dpl were not in close contact with Flk1-GFP-positive endothelial cells. It has been reported that PDGFRβ+ vascular mural cells proliferate extensively into fibroblast-like cells that generate fibrous extracellular matrices (ECM) in MCAO model, spinal cord injury, and tumor [4, 6, 11] . The PDGFRβ+ cells also expressed fibronectin, a fibroblast marker, in the demyelinated lesion at 7 dpl (Fig.4E) . Hence there is a possibility that PDGFRβ+ cells not in close contact with blood vessels might be involved in scar formation in white matter infarct.
In this study, we revealed revascularization begins early after the ischemic insult on the white matter, and the emerging pericytes first ensheath blood vessels and then produce fibroblast-like cells. The roles these fibroblast-like cells play in the recovery process of the white matter infarct remain unclear at present and further study is required to answer this important question.
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